Full Text View
Tabular View
Study Results
Related Studies
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
This study has been completed.
Study NCT00424398   Information provided by Bausch & Lomb Incorporated

First Received on January 17, 2007.   Last Updated on February 13, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Conjunctivitis, Allergic
Additional conditions recognized in this trial
Conjunctivitis
More general conditions related to this trial
Conjunctival Diseases
Eye Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Interventions listed in this trial
Bepreve
Placebo
Bepotastine Besilate
Sponsors listed in this trial
Bausch & Lomb Incorporated


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services